The Quattroflow QF20KSU single-use quaternary pump for biopharmaceutical processing reduces contamination risk and downtime.
Quattroflow QF1200-HT single- and multi-use pumps. Image courtesy of PSG.
Quattroflow, part of PSG, a Dover company, will introduce the new QF20KSU single-use pump at INTERPHEX in Booth No. 2253. The pump features replaceable polypropylene wetted pump chambers, which can be easily replaced as a complete unit between batches to eliminate sterilization, lower cross-product contamination risk, and reduce downtime. The QF20KSU features flow rates of 200–16,000 Lph (53–4227 gph), 51 mm (2 in.) connections, and autoclave and gamma irradiation capabilities.
Quattroflow QF1200-HT single- and multi-use pumps have a high turndown ratio for precise accuracy in controlling flow rates. Their compact design with integrated controller provides a plug-and-play solution for applications requiring precision flow control, quick batch changes, and a small footprint. The QF1200-HT offers flow rates of 6–1200 Lph (1.6–317 gph) and 19-mm (3/4 in.) connections.
Quattroflow pumps are used in a wide range of biopharmaceutical applications requiring gentle product handling, high containment, low pulsation, purity, and cleanability. Unlike peristaltic and lobe pumps, Quattroflow quaternary pumps use no moving parts to provide non-slip operation, which is optimal for transferring shear-sensitive products without damage, while virtually eliminating particle generation and heat degradation. The pumps are self-priming, provide safe dry-run operation, and allow for clean-in-place (CIP), sterilize-in-place (SIP), and autoclave capabilities.
Source: PSG
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of Forced Degradation in Method Development, Manufacturability, and CMC Strategy
April 28th 2025Forced degradation studies are critical in biologics development, particularly for monoclonal antibodies (mAbs). These studies simulate long-term environmental stressors to uncover degradation pathways and ensure the stability of critical quality attributes (CQAs), aiding in robust chemistry, manufacturing, and controls (CMC) strategies and regulatory compliance.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.